| Literature DB >> 30999727 |
Nehal Mohamed El Koofy1, Hanaa Ibrahim Rady1, Shrouk Moataz Abdallah1, Hafez Mahmoud Bazaraa1, Walaa Ahmed Rabie2, Ahmed Ali El-Ayadi1.
Abstract
BACKGROUND: Ventilator dependency constitutes a major problem in the intensive care setting. Malnutrition is considered a major determinant of extubation failure, however, attention has been attracted to modulating carbon dioxide production through decreasing carbohydrate loading and increasing the percent of fat in enteral feeds. The detected interrelation between substrate oxidation and ventilation outcome became the base of several research to determine the appropriate composition of the nonprotein calories of diet in ventilated patients.Entities:
Keywords: Critical illness; Enteral nutrition; High fat diet; Malnutrition; Pulmonary disease
Year: 2019 PMID: 30999727 PMCID: PMC6753313 DOI: 10.3345/kjp.2018.06835
Source DB: PubMed Journal: Korean J Pediatr ISSN: 1738-1061
Demographic characteristics of the study groups
| Characteristic | All (n=51) | Group A (n=25) | Group B (n=26) | |
|---|---|---|---|---|
| Age (mo) | 12 (3.7–31.5) | 12 (3.7–51) | 10 (3–24) | 0.93 |
| Sex | ||||
| Male | 32 (62.7) | 16 (64) | 16 (61.5) | 0.85 |
| Female | 19 (37.3) | 9 (36) | 10 (38.5) | |
| Enrollment groups | ||||
| Early (within 48 hr) | 35 (68.6) | 20 (80) | 15 (57.7) | 0.08 |
| Late (>48 hr) | 16 (31.4) | 5 (20) | 11 (42.3) | |
| PIM-2 | 13.5 (5.3–28.2) | 10.2 (5.75–27.7) | 17.1 (5.2–28.8) | 0.27 |
| Acute respiratory condition | ||||
| Pneumonia | 47 (92.1) | 21 (84) | 26 (100) | 0.20 |
| ARDS | 3 (5.9) | 3 (12) | 0 (0) | |
| Status asthmaticus | 1 (2) | 1 (4) | 0 (0) | |
| Chronic respiratory condition | 10 (19.6) | 6 (24) | 4 (15.4) | 0.66 |
| Upper airway | ||||
| Laryngomalacia | 2 (3.9) | 0 (0) | 2 (7.7) | |
| Adenoid hypertrophy | 1 (2) | 1 (4) | 0 (0) | |
| Lower airway | ||||
| Undiagnosed | 3 (5.9) | 3 (12) | 0 (0) | |
| Persistent asthma | 1 (2) | 1 (4) | 0 (0) | |
| Cystic fibrosis | 1(2) | 1 (4) | 0 (0) | |
| Tuberculous lung fibrosis | 1 (2) | 0 (0) | 1 (3.8) | |
| BPD | 1 (2) | 0 (0) | 1 (3.8) | |
| Neurological disorder | 25 (49) | 5 (20) | 20 (77) | 0.003 |
| Acute | ||||
| Convulsions | 4 (7.8) | 1 (4) | 3 (11.5) | |
| Intracranial hemorrhage | 2 (4) | 0 (0) | 2 (7.7) | |
| Toxic encephalopathy | 1 (2) | 1 (4) | 0 (0) | |
| CNS infection | 1 (2) | 0 (0) | 1 (3.8) | |
| Chronic | ||||
| Hydrocephalus | 5 (9.8) | 1 (4) | 4 (15.4) | |
| Cerebral palsy | 3 (5.8) | 2 (8) | 1 (3.8) | |
| Neurodegenerative disease | 4 (7.8) | 1 (4) | 3 (12) | |
| Cystic encephalomalacia | 1 (2) | 0 (0) | 1 (3.8) | |
| GBS | 3 (5.9) | 0 (0) | 3 (11.5) | |
| Pompe disease | 1 (2) | 0 (0) | 1 (3.8) | |
| Cardiac diagnosis | 10 (25) | 3 (20) | 7 (26.9) | |
| Congenital heart disease | 0.60 | |||
| Cyanotic | 3 (7.5) | 0 (0) | ||
| Acyanotic | 5 (12.5) | 2 (13.3) | ||
| Acquired heart disease | ||||
| DCM | 1 (2.5) | 0 (0) | 1 (4) | |
| Kawasaki | 1 (2.5) | 1 (6.7) | 0 (0) | |
| Immunological (SCID) | 1 (2) | 1 (4) | 0 (0) | 0.66 |
The prevalence of malnutrition among the study groups
| Malnutrition prevalence | All (n=51) | Group A (n=25) | Group B (n=26) | |
|---|---|---|---|---|
| Weight/age ( | ||||
| More than -2 SD | 11 (21.6) | 6 (24) | 5 (19.2) | |
| -2 to -3 SD | 16 (31.4) | 11 (44) | 5 (19.2) | |
| Less than -3 SD | 19 (37.3) | 4 (16) | 15 (57.7) | |
| Weight/length ( | ||||
| More than -2 SD | 14 (27.5) | 8 (32) | 6 (23.1) | |
| -2 to -3 SD | 12 (23.5) | 8 (32) | 4 (15.4) | |
| Less than -3 SD | 20 (39.2) | 5 (9.8) | 15 (57.7) | |
| BMI/age ( | ||||
| More than -2 SD | 15 (29.4) | 8 (32) | 7 (26.9) | |
| -2 to -3 SD | 11 (21.6) | 8 (32) | 3 (11.5) | |
| Less than -3 SD | 20 (39.2) | 5 (9.8) | 15 (57.7) | |
| MUAC/age ( | ||||
| More than -2 SD | 15 (29.4) | 9 (36) | 6 (23.1) | |
| -2 to -3 SD | 6 (11.7) | 1 (4) | 5 (19.2) | 0.18 |
| Less than -3 SD | 17 (33.3) | 7 (28) | 10 (38.5) |
Values are presented as number (%).
Group A, high fat feeding group; group B, standard feeding group; SD, standard deviation; BMI, body mass index; MUAC, mid-upper arm circumference.
Boldface indicates a statistically significant difference with P<0.05.
Outcome parameters of the study groups
| Outcome parameter | Group A (n=25) | Group B (n=26) | |
|---|---|---|---|
| MV mode | |||
| Day 1 | |||
| SIMV | 21 (84) | 24 (92.3) | 0.31 |
| HFOV | 2 (8) | 1 (3.8) | |
| PRVC | 2 (8) | 0 (0) | |
| ET-CPAP | 0 (0) | 1 (3.8) | |
| Day 7 | |||
| SIMV | 10 (40) | 9 (34.6) | 0.81 |
| HFOV | 1 (4) | 1 (3.8) | |
| PRVC | 1 (4) | 0 (0) | |
| PSV | 0 (0) | 1 (3.8) | |
| ET-CPAP | 2 (8) | 3 (11.5) | |
| | |||
| Assisted minute ventilation (L/m2/ min) | |||
| Day 1 | 5.86 (3.6–8.9) | 4.52 (3.3–6.9) | 0.23 |
| Day 7 | 6.19 (4.7–7.8) | 8.17 (4.5–10.8) | 0.36 |
| | 0.08 | 0.74 | |
| pH | |||
| Day 1 | 7.37±0.1 | 7.46±0.1 | 0.06 |
| Day 7 | 7.46±0.1 | 7.45±0.1 | 0.71 |
| | 0.81 | ||
| pCO2 | |||
| Day 1 | 47±15.1 | 42.24±15.9 | 0.11 |
| Day 7 | 37.98±8.3 | 42.14±13.4 | 0.22 |
| | 0.97 | ||
| Albumin (g/dL) | |||
| Day 1 | 3.4 (2.8–3.7) | 3.65 (3.1–4.3) | |
| Day 7 | 3.1 (2.8–3.5) | 3.45 (2.7–3.8) | 0.07 |
| | 0.11 | ||
| Prealbumin (mg/dL) | |||
| Day 1 | 8.25 (4.5–11.5) | 11.05 (7.2–13.4) | 0.23 |
| Day 7 | 11.75 (8.7–20.7) | 15.1 (11.4–19.2) | 0.52 |
| | 0.19 | ||
| Triglycerides (mg/dL) | |||
| Day 1 | 165 (74–232) | 150 (127.3–199.3) | 0.95 |
| Day 7 | 216.5 (173.8–346) | 158 (151–257) | 0.11 |
| | 0.41 | ||
| Nutritional facts at day 7 | |||
| % proteins achieved | 50 (48.8–75) | 50 (33.3–100) | 0.62 |
| % calories achieved | 60 (40–83) | 49.5 (23.8–100) | 0.75 |
| Day-7 outcomes | |||
| Extubated | 8 (32) | 7 (27) | |
| Not extubated | 15 (60) | 15 (57.6) | 0.70 |
| Dead | 2 (8) | 4 (15.4) | |
| Day-14 outcome | |||
| Extubated | 9 (36) | 2 (7.6) | |
| Not extubated | 10 (40) | 12 (46) | |
| Dead | 4 (16) | 10 (38.4) | |
| Final outcome | |||
| Death | 12 (48) | 18 (69.2) | 0.16 |
| Discharge | 11 (44) | 5 (19.2) | |
| Admitted | 2 (8) | 3 (11.5) |
Values are presented as number (%), median (interquartile range), or mean±standard deviation.
Group A, high fat feeding group; group B, standard feeding group; MV, mechanical ventilation; SIMV, synchronized intermittent mandatory ventilation; HOFV, high-frequency oscillatory ventilation; PRVC, pressure regulated volume control; PSV, pressure support ventilation; ET-CPAP, endotracheal continuous positive airway pressure.
P value for differences between the groups A and B.
P value for differences before and after the intervention (day 1 and day 7 of enrollment) for each group.
Boldface indicates a statistically significant difference with P<0.05.
Multiple group comparisons for day-14 outcome
| Parameter | Extubated | Not extubated | Dead | ||
|---|---|---|---|---|---|
| Weight for length | -0.7 (-2.1 to 0.4) | -2.7 (-4.8 to -0.4) | -2.9 (-5.5 to -2.2) | ||
| Weight for age | -1.4 (-2.5 to -1) | -2.9 (-4.8 to -2.5) | -3.6 (-4.6 to -2.6) | 0.03 | |
| BMI for age | -0.6 (-2.1 to 0.5) | -3.7 (-5.1 to 0.4) | -2.8 (-5.6 to -2.1) | 0.04 | |
| PIM-2 | 6.2 (4.2–11.4) | 15.7 (4.7–30.6) | 27.1 (19.4–34.75) | ||
| Albumin | |||||
| Day 1 | 3.7 (3.1–4) | 3.5 (2.9–4) | 3 (2.5–3.4) | ||
| Day 7 | 3.6 (2.9–3.9) | 3.2 (2.6–3.7) | 28 (1.9–3.5) | ||
| Prealbumin | |||||
| Day 1 | 10.1 (7.3–11.8) | 10 (7.1–14.4) | 6.4 (3.7–11.3) | ||
| Day 7 | 20.5 (9.2–23.8) | 14.6 (10.1–18.7) | 8.5 (2.1–9.4) |
Values are presented as median (interquartile range).
BMI, body mass index, PIM-2, pediatric index of mortality score 2.
P value comparing the patients who were extubated to those who were dead at day-14 of enrollment.
P value comparing the patients who were still ventilated to those who were dead at day-14 of enrollment.
Boldface indicates a statistically significant difference with P<0.05.
Fig. 1.Weight-for-age and caloric intake as predictors of assisted minute ventilation at day 7.
Multiple group comparisons for the final outcome
| Parameter | Dead | Discharged | |
|---|---|---|---|
| Anthropometry at day 1 ( | |||
| Weight for length | -3.4 (-5.2 to -2.1) | -1 (-3.2 to 0.2) | |
| Weight for age | -3.7 (-5.6 to -2.6) | -1.5 (-3.3 to -1) | |
| MUAC for age | -4 (-5.1 to -1.5) | -0.2 (-3.2 to 0.7) | |
| BMI for age | -3.9 (-6.1 to -2.3) | -1 (-3.2 to 0.3) | |
| Mortality scoring | |||
| PIM-2 (%) | 21.9 (10.2–31) | 8.4 (5.2–13.5) | |
| Laboratory parameters | |||
| Prealbumin day 7 (mg/dL) | 11 (8.5–15.8) | 16.3 (10.6–23.1) |
Values are presented as median (interquartile range).
MUAC, midupper arm circumference; BMI, body mass index; PIM-2, pediatric index of mortality score 2.
Boldface indicates a statistically significant difference with P<0.05.
Fig. 2.Stepwise regression analysis showing mid-upper arm circumference (MUAC)-for-age as the strongest predictor of the final outcome. SD, standard deviation.